EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Temporal Changes in Reporting of Neurodevelopmental Outcomes After Maternal Exposure to Valproate: A Contribution of the ConcePTION Project

Dimitra Gkolfi, Yrea R J van Rijt-Weetink, Henric Taavola-Gustafsson, Lovisa Sandberg, Boukje C Raemaekers, Florence P A M van Hunsel, Anneke L M Passier, Rebecca L Bromley, Laura M Yates, Eugène P van Puijenbroek

Drug Safety · 2025

DOI: 10.1007/s40264-025-01583-0 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Drug Safety, 2025. Verfasst von Dimitra Gkolfi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Valproic Acid, Prenatal Exposure Delayed Effects, Anticonvulsants, Neurodevelopmental Disorders. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Innovative Medicines Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Understanding changes over time in the quantity and characteristics of reports submitted to pharmacovigilance centres is crucial for accurately interpreting safety signals associated with exposure during pregnancy. OBJECTIVE: We aimed to assess temporal changes in the outcome measures for signal detection, specifically the number and clustering of reported adverse events concerning maternal valproate exposure and neurodevelopmental outcomes in offspring. METHODS: An observational study using VigiBase analysed changes in the number of reports and event clustering related to neurodevelopmental outcomes in offspring following valproate exposure during pregnancy. Reports from the start of VigiBase till 3 April, 2023 were identified using the VigiBase pregnancy algorithm. Time trend graphs illustrated reporting behavioural changes, with particular focus on the impact of major scientific publications and regulatory decisions. Report clusters, identified by the vigiGroup method, were randomised and independently reviewed by three qualified reviewers for clinical relevance to neurodevelopmental outcomes, morphological disorders or other entities. RESULTS: Over time, an increase in reports mentioning neurodevelopmental outcomes and a more diverse pattern of adverse events for valproate has been reported. An increase in the number of reports following key publications and international regulatory guidelines was visible. CONCLUSIONS: Our study revealed an increase over time in reporting and awareness of neurodevelopmental outcomes and valproate exposure during pregnancy, following important publications and regulatory decisions. However, the extent to which these developments contributed to the observed increase remains unclear.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Valproic AcidPrenatal Exposure Delayed EffectsAnticonvulsantsNeurodevelopmental DisordersAdverse Drug Reaction Reporting SystemsMaternal ExposureHumansFemalePregnancyPharmacovigilanceTime FactorsAdult

Substanzen

Valproic AcidAnticonvulsants

Autor:innen und Institutionen

  • Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands.
  • Uppsala Monitoring Centre, Uppsala, Sweden.
  • Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands.
  • Division of Neuroscience, University of Manchester, Manchester, UK.
  • Royal Manchester Children's Hospital, Manchester, UK.
  • University of Kwazulu-Natal, KRISP, Durban, South Africa.

Förderung

  • Innovative Medicines Initiative

Zitieren

APA

Gkolfi, D., van Rijt-Weetink, Y. R. J., Taavola-Gustafsson, H., Sandberg, L., Raemaekers, B. C., van Hunsel, F. P. A. M., Passier, A. L. M., Bromley, R. L., Yates, L. M., & van Puijenbroek, E. P. (2025). Temporal Changes in Reporting of Neurodevelopmental Outcomes After Maternal Exposure to Valproate: A Contribution of the ConcePTION Project. Drug Safety. https://doi.org/10.1007/s40264-025-01583-0

Vancouver

Gkolfi D, van Rijt-Weetink YRJ, Taavola-Gustafsson H, Sandberg L, Raemaekers BC, van Hunsel FPAM, et al. Temporal Changes in Reporting of Neurodevelopmental Outcomes After Maternal Exposure to Valproate: A Contribution of the ConcePTION Project. Drug Safety. 2025. doi:10.1007/s40264-025-01583-0

BibTeX
@article{Gkolfi2025,
  author = {Gkolfi, Dimitra and van Rijt-Weetink, Yrea R J and Taavola-Gustafsson, Henric and Sandberg, Lovisa and Raemaekers, Boukje C and van Hunsel, Florence P A M and Passier, Anneke L M and Bromley, Rebecca L and Yates, Laura M and van Puijenbroek, Eugène P},
  title = {Temporal Changes in Reporting of Neurodevelopmental Outcomes After Maternal Exposure to Valproate: A Contribution of the ConcePTION Project},
  journal = {Drug Safety},
  year = {2025},
  doi = {10.1007/s40264-025-01583-0}
}
Kostenlos starten →